Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Effects on Fear Extinction in Social Phobia
NCT06123702Phase 1Not yet recruiting
- Sponsor
- Hartford Hospital
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Skin conductance and Distress ratings. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT06123702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06123702.